ARCHIVES

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

Former FDA Commissioner Lester Crawford Pleads Guilty to Filing False Reports About His Ownership of Stocks in Health, Food, Biotech Companies.

October 20, 2006

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

Advances Found In Treatment Of Aerodigestive Cancers

May 25, 2001

Also in this 8-page issue: Amendment strips funding from two NIHM grants. NCI will commit $7 million to begin restructuring its clinical trials system, Institute director says.

July 1, 2005

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008